Nephrology (literally the study of the kidney) has evolved over the last 60 years to become a major medical specialty. Early pioneering renal physiology experiments yielded insights into blood pressure regulation, electrolyte and acid-base balance. This physiological research, coupled with advances in immunology, was translated into effective life sustaining therapy for chronic kidney failure (dialysis and kidney transplantation). Nephrology now encompasses a wide range of clinical treatments for acute kidney injury, chronic kidney disease, end-stage renal failure, bone mineral metabolism, renal anaemia and prevention of kidney transplant rejection.
Where is Nephrology goiNg as a specialty?
Renal medicine has experienced unprecedented growth over the past 20 years driven in part by the rising number of persons with end-stage kidney failure needing dialysis and/ or renal transplantation. Visible evidence of the increased numbers of patients requiring renal replacement therapy is the development of multiple new renal units both in teaching hospitals and district general hospitals.
hoW are Nephrologists traiNed?
Training in nephrology follows the nationally agreed renal medicine curriculum and is competency based. Entry to training is by competitive multi-station interview and from 2010 applicants will need to have attained MRCP (UK) PACES or equivalent prior to application. Typically it will take a total of three years of clinical nephrology training to attain a CCT in Renal Medicine. During this period the specialist trainee will rotate between the sub-disciplines of nephrology including transplantation, dialysis, general nephrology and consult services with a minimum of 3 months acute kidney transplant experience (managing patients in the peri-operative and early phases of kidney transplantation). Procedural skill in placing ultrasound-guided central venous catheters for dialysis (Figure 1 ) is a mandatory component of training. Developing expertise in native and transplant kidney biopsy (Figure 2 ) is encouraged but is no longer an essential requirement of training. During training the Specialty Certificate Examination (SCE), organised by the Royal College of Physicians, must be passed. This is an MCQ exam based on the Renal Medicine Curriculum approved by PMETB
caN i combiNe reNal mediciNe With other iNterests?
A majority of trainees also enrol for training in general internal medicine to attain a dual CCT in medicine and nephrology. This is a pragmatic choice recognising that many nephrology posts are in hospitals where the consultant nephrologist contributes to the acute medical take in. Some nephrology trainees, and particularly those with a special interest in acute kidney injury, have combined renal medicine and intensive care medicine training and forge a career in the interface areas between critical care and nephrology. A small number of trainees have entered a clinical academic training pathway e.g. academic clinical fellow (ACF) or academic clinical lecturer (ACL) and combine nephrology training with extended periods of research and teaching. An academic pathway will lead to a postgraduate degree e.g. MD or PhD and for some particularly tenacious individuals, who secure additional peer-reviewed funding, it can lead to the first steps on a clinical academic career ladder. The best aspects are learning to apply knowledge, skills and aptitudes to solve challenging problems. There are excellent teaching and research opportunities. The specialty is growing and a career in nephrology is secure and rewarding.
The worst aspects are arguably the frustration of not being able to provide optimal care to some patients e.g. shortage of donor organs for kidney transplantation
What are the uNsolved challeNges iN Nephrology?
Acute kidney injury (AKI) is common, expensive to manage and associated with a high mortality. Surprisingly there is still limited evidence for any therapeutic regimen to prevent or treat AKI apart from ensuring optimal fluid resuscitation and avoidance of obvious nephrotoxins. There is an urgent need for new strategies to reduce the risk of AKI and accelerate recovery of injured kidneys. Chronic kidney disease (CKD), defined as an estimated glomerular filtration rate (eGFR) of <60mL/min/1.73m 2 is present in up to 5% of the adult population. CKD is associated with an increased risk of cardiovascular events and premature death, particularly when the eGFR is <30mL/min/1.73m 2 . The pathophysiology of accelerated cardiovascular risk associated with kidney disease is incompletely understood and is currently a very active research field. Polycystic kidney disease (PKD) is the commonest monogenic cause of kidney disease and hypertension. The molecular and cell biology of cyst growth in PKD is now much better understood and an exciting era of clinical trials is now underway with drugs for prevention of kidney failure secondary to PKD. Renal transplantation is the optimal form of renal replacement therapy for many patients with end-stage renal failure. The holy grail of transplant research is the achievement of immune tolerance that would permit organ transplantation without exposing patients to the long-term risks of immunosuppressant drugs. There is still a wide range of interesting clinical and basic science research questions to answer in renal medicine. The future, for trainees and consultants, will be full of opportunities to translate research findings into better care for persons with kidney disease.
i WaNt to kNoW more -Where should i go Next?
Nationally, information relevant to prospective UK-based renal trainees is available on the Renal Association website (www.renal.org). The Renal Medicine curriculum is published on the PMETB website (www.pmetb.org.uk) and located in approved curricula section.
